JP2010529212A5 - - Google Patents

Download PDF

Info

Publication number
JP2010529212A5
JP2010529212A5 JP2009551999A JP2009551999A JP2010529212A5 JP 2010529212 A5 JP2010529212 A5 JP 2010529212A5 JP 2009551999 A JP2009551999 A JP 2009551999A JP 2009551999 A JP2009551999 A JP 2009551999A JP 2010529212 A5 JP2010529212 A5 JP 2010529212A5
Authority
JP
Japan
Prior art keywords
poz
compound
group
functional group
active functional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009551999A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010529212A (ja
JP5615558B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/002626 external-priority patent/WO2008106186A2/en
Publication of JP2010529212A publication Critical patent/JP2010529212A/ja
Publication of JP2010529212A5 publication Critical patent/JP2010529212A5/ja
Application granted granted Critical
Publication of JP5615558B2 publication Critical patent/JP5615558B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009551999A 2007-02-28 2008-02-28 活性ポリオキサゾリンおよびそれを含む組成物 Active JP5615558B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89221207P 2007-02-28 2007-02-28
US60/892,212 2007-02-28
PCT/US2008/002626 WO2008106186A2 (en) 2007-02-28 2008-02-28 Activated polyoxazolines and compositions comprising the same

Publications (3)

Publication Number Publication Date
JP2010529212A JP2010529212A (ja) 2010-08-26
JP2010529212A5 true JP2010529212A5 (enExample) 2011-04-07
JP5615558B2 JP5615558B2 (ja) 2014-10-29

Family

ID=39721806

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009551999A Active JP5615558B2 (ja) 2007-02-28 2008-02-28 活性ポリオキサゾリンおよびそれを含む組成物

Country Status (6)

Country Link
US (1) US7943141B2 (enExample)
EP (1) EP2134181A4 (enExample)
JP (1) JP5615558B2 (enExample)
KR (2) KR101508617B1 (enExample)
CN (2) CN106046370A (enExample)
WO (1) WO2008106186A2 (enExample)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009043027A2 (en) * 2007-09-27 2009-04-02 Serina Therapeutics, Inc. Multi-armed forms of activated polyoxazoline and methods of synthesis thereof
US8101706B2 (en) * 2008-01-11 2012-01-24 Serina Therapeutics, Inc. Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
US8110651B2 (en) 2008-01-11 2012-02-07 Serina Therapeutics, Inc. Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
KR101671537B1 (ko) 2008-08-11 2016-11-01 넥타르 테라퓨틱스 다분지형 중합체 알카노에이트 컨쥬게이트
US20110318322A1 (en) 2009-01-12 2011-12-29 Nektar Therapeutics Conjugates of a Lysosomal Enzyme Moiety and a Water Soluble Polymer
ES2866674T3 (es) 2010-11-12 2021-10-19 Nektar Therapeutics Conjugados de una fracción de IL-2 y un polímero
US20130331443A1 (en) 2010-12-22 2013-12-12 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
WO2012166555A1 (en) 2011-05-27 2012-12-06 Nektar Therapeutics Water - soluble polymer - linked binding moiety and drug compounds
US20160024252A1 (en) * 2011-08-03 2016-01-28 Anp Technologies, Inc. Oxazoline Polymer Compositions and Use Thereof
WO2013020079A2 (en) 2011-08-04 2013-02-07 Nektar Therapeutics Conjugates of an il-11 moiety and a polymer
US8383093B1 (en) 2011-11-01 2013-02-26 Serina Therapeutics, Inc. Subcutaneous delivery of poly(oxazoline) conjugates
US9416228B2 (en) * 2012-03-16 2016-08-16 Bender Analytical Holding B.V. Cross-linked polymers and medical products derived from nucleophilically activated polyoxazoline
US10035822B2 (en) 2012-11-15 2018-07-31 Apellis Pharmaceuticals, Inc. Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
CN103897181B (zh) * 2012-12-27 2017-02-08 张昊 聚合物、其制备方法和应用
US9215876B2 (en) 2014-03-24 2015-12-22 International Business Machines Corporation 1,3,6-dioxazocan-2-ones and antimicrobial cationic polycarbonates therefrom
US9624191B2 (en) 2014-03-24 2017-04-18 International Business Machines Corporation Cyclic carbonate monomers and ring opened polycarbonates therefrom
GB201405391D0 (en) * 2014-03-26 2014-05-07 Applied Biomimetic As Novel polymers and process for making membranes
MA39711A (fr) 2014-04-03 2015-10-08 Nektar Therapeutics Conjugués d'une fraction d'il-15 et d'un polymère
BR112017000911B1 (pt) 2014-07-18 2023-04-11 Universiteit Gent Método para preparação de polímeros uniformes de iminoéter cíclico tendo massa molar elevada
US10071168B2 (en) * 2014-07-31 2018-09-11 Serina Therapeutics, Inc. Polyoxazoline antibody drug conjugates
JP6683398B2 (ja) 2014-10-06 2020-04-22 ガット テクノロジーズ ビー.ブイ.Gatt Technologies B.V. 組織接着性多孔質止血製品
IL254389B2 (en) 2015-03-11 2023-03-01 Nektar Therapeutics Polymer conjugates and the il–7 group
KR20180090785A (ko) 2015-10-07 2018-08-13 아펠리스 파마슈티컬스 인코포레이티드 투여 요법
WO2017062832A1 (en) 2015-10-08 2017-04-13 Nektar Therapeutics Combination of an il-2rbeta-selective agonist and a long-acting il-15 agonist
BR112019020955A2 (pt) 2017-04-07 2020-05-05 Apellis Pharmaceuticals, Inc. regimes de dosagem e composições e métodos relacionados
KR20250057110A (ko) 2017-05-15 2025-04-28 넥타르 테라퓨틱스 지속 작용성 인터류킨-15 수용체 효현제 및 관련 면역요법 조성물 및 방법
TWI821192B (zh) 2017-07-11 2023-11-11 美商新索思股份有限公司 非天然核苷酸之導入及其方法
IL321812A (en) 2017-08-03 2025-08-01 Synthorx Inc Cytokine complexes for the treatment of autoimmune diseases
EP3502217B1 (en) * 2017-11-29 2020-05-27 Infineum International Limited Lubricating oil compositions
US10822569B2 (en) 2018-02-15 2020-11-03 Afton Chemical Corporation Grafted polymer with soot handling properties
AU2019224159B2 (en) 2018-02-26 2025-05-29 Sanofi IL-15 conjugates and uses thereof
US10851324B2 (en) 2018-02-27 2020-12-01 Afton Chemical Corporation Grafted polymer with soot handling properties
CN110865055B (zh) * 2018-08-27 2022-10-25 香港科技大学 无金属偶联方法、偶联物及其应用
US10899989B2 (en) 2018-10-15 2021-01-26 Afton Chemical Corporation Amino acid grafted polymer with soot handling properties
TW202031284A (zh) 2018-11-08 2020-09-01 美商新索思股份有限公司 介白素10結合物及其用途
US11046908B2 (en) 2019-01-11 2021-06-29 Afton Chemical Corporation Oxazoline modified dispersants
MA54952A (fr) 2019-02-06 2022-05-11 Synthorx Inc Conjugués d'il-2 et méthodes d'utilisation de ceux-ci
US12485181B2 (en) 2019-06-28 2025-12-02 Serina Therapeutics (Al), Inc. Polyoxazoline-drug conjugates with novel pharmacokinetic properties
JP7626404B2 (ja) * 2019-07-30 2025-02-04 ガット テクノロジーズ ビー.ブイ. カルシウム結合基を含むポリオキサゾリンコポリマー
WO2021050554A1 (en) 2019-09-10 2021-03-18 Synthorx, Inc. Il-2 conjugates and methods of use to treat autoimmune diseases
WO2021067458A1 (en) 2019-09-30 2021-04-08 Beijing Xuanyi Pharmasciences Co., Ltd. Protein-macromolecule conjugates and methods of use thereof
KR102986821B1 (ko) 2020-04-22 2026-07-06 머크 샤프 앤드 돔 엘엘씨 인터류킨-2 수용체 베타 감마c 이량체에 대해 편향되고 비펩티드성 수용성 중합체에 접합된 인간 인터류킨-2 접합체
WO2022173667A1 (en) 2021-02-09 2022-08-18 Serina Therapeutics, Inc. Polyoxazoline-lipid conjugates and lipid nanoparticles and pharmaceutical compositions including same
EP4763287A2 (en) 2021-09-03 2026-06-24 CureVac SE Novel lipid nanoparticles for delivery of nucleic acids
IL309502A (en) 2021-09-03 2024-02-01 CureVac SE Lipid nanoparticles for nucleic acid delivery involving phosphatidylserine
EP4422698A1 (en) 2021-10-29 2024-09-04 CureVac SE Improved circular rna for expressing therapeutic proteins
EP4469091A1 (en) 2022-01-28 2024-12-04 CureVac SE Nucleic acid encoded transcription factor inhibitors
WO2023144792A1 (en) 2022-01-31 2023-08-03 Genevant Sciences Gmbh Poly(alkyloxazoline)-lipid conjugates and lipid particles containing same
CN114685784B (zh) * 2022-04-26 2023-09-15 北京清科胜因生物科技有限公司 一种用于核酸递送的聚(2-噁唑啉)脂质与脂质纳米颗粒及应用
CN114940756B (zh) * 2022-06-02 2023-11-07 北京清科胜因生物科技有限公司 一种聚(2-噁唑啉)脂质与脂质纳米颗粒及应用
WO2024098023A2 (en) 2022-11-04 2024-05-10 Sutro Biopharma, Inc. Interferon alpha polypeptides and conjugates
KR20250153298A (ko) 2023-03-08 2025-10-24 큐어백 에스이 핵산 전달을 위한 신규의 지질 나노입자 제형
WO2024230934A1 (en) 2023-05-11 2024-11-14 CureVac SE Therapeutic nucleic acid for the treatment of ophthalmic diseases
WO2025158385A1 (en) 2024-01-25 2025-07-31 Genzyme Corporation Pegylated il-2 for suppressing adaptive immune response to gene therapy
CN118459756A (zh) * 2024-05-07 2024-08-09 南京师范大学 一种温敏性材料和糖缀合物及其合成方法和在糖固相合成中的应用
EP4656669A1 (en) 2024-05-28 2025-12-03 Arkema France Fluorinated copolymers based on an oligo(2-oxazoline) macromonomer
WO2026050140A1 (en) * 2024-08-26 2026-03-05 Board Of Regents, The University Of Texas System Surface modified dendrimer for controlled release of active ingredients into the skin
WO2026055280A1 (en) 2024-09-04 2026-03-12 Sanofi Interleukin 2 (il-2) and cd123 nk cell engager combination therapy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2643403B2 (ja) * 1989-01-10 1997-08-20 花王株式会社 ポリ(n―アシルアルキレンイミン)系共重合体及びその用途
US5635571A (en) * 1995-06-30 1997-06-03 Cornell Research Foundation, Inc. Polymerizable macromonomers and polymers prepared therefrom
US5672662A (en) * 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
KR20030097876A (ko) * 2001-05-21 2003-12-31 넥타르 테라퓨틱스 화학적으로 개질된 인슐린의 폐 투여
US6908963B2 (en) * 2001-10-09 2005-06-21 Nektar Therapeutics Al, Corporation Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith
US7056500B2 (en) * 2001-10-18 2006-06-06 Nektar Therapeutics Al, Corporation Polymer conjugates of opioid antagonists
WO2003066069A1 (en) * 2002-02-01 2003-08-14 Intradigm Corporation Polymers for delivering peptides and small molecules in vivo
EP1725262B1 (en) * 2004-03-15 2021-05-26 Nektar Therapeutics Polymer-based compositions and conjugates of hiv entry inhibitors
US8057821B2 (en) * 2004-11-03 2011-11-15 Egen, Inc. Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
EP1930361B1 (en) * 2005-09-01 2014-04-16 Japan Science and Technology Agency Random copolymer of oxazoline

Similar Documents

Publication Publication Date Title
JP2009521545A5 (enExample)
JP5514736B2 (ja) ポリオキサゾリン共重合体の多機能形態およびそれを含む薬物組成物
JP2016525466A5 (enExample)
JP2010535870A5 (enExample)
JP5846125B2 (ja) アミノ基含有ホスホリルコリン化合物及びその製造方法
JP2004535485A5 (enExample)
JP2006520339A5 (enExample)
JP2012520247A5 (enExample)
JP2008540658A5 (enExample)
JPWO2021049504A5 (enExample)
JP2010529212A (ja) 活性ポリオキサゾリンおよびそれを含む組成物
JP2007077384A5 (enExample)
JP2010534246A5 (enExample)
JP2008540414A5 (enExample)
JP2010540488A5 (enExample)
JP2006225632A5 (enExample)
JPWO2022215652A5 (enExample)
ES3022732T3 (en) Azide-functionalized copolymers
JP2008222908A5 (enExample)
JP2006524231A5 (enExample)
EP1363878B1 (en) Process for preparing sulfamoyl-substituted phenethylamine derivatives
JP2013234160A (ja) カルボキシル基含有ホスホリルコリン化合物及びその製造方法
JP2013544876A5 (enExample)
JP2007154091A5 (enExample)
JP2003034704A5 (enExample)